{"acute kidney injury": 8.38, "aplasia pure red cell": 11.33, "aspergillus infection": 16.3, "blood creatinine increased": 5.76, "bronchopulmonary aspergillosis": 20.47, "candida infection": 18.69, "complications of transplanted kidney": 50.29, "contraindicated product administered": 4.29, "cytomegalovirus infection": 16.98, "cytomegalovirus infection reactivation": 16.41, "cytomegalovirus viraemia": 22.92, "delirium": 2.59, "diabetes mellitus": 2.15, "drug interaction": 32.59, "drug level decreased": 41.32, "drug level increased": 69.54, "electrocardiogram qt prolonged": 4.16, "electrolyte imbalance": 9.17, "epstein-barr virus infection": 16.71, "exposure during pregnancy": 3.77, "foetal exposure during pregnancy": 4.79, "fungal infection": 6.25, "generalised tonic-clonic seizure": 2.63, "graft versus host disease": 22.71, "hyperkalaemia": 19.82, "hyponatraemia": 2.26, "immunosuppressant drug level decreased": 213.32, "immunosuppressant drug level increased": 313.44, "kidney transplant rejection": 32.11, "labelled drug-drug interaction medication error": 8.61, "leukopenia": 2.95, "liver transplant rejection": 92.72, "mental status changes": 5.45, "multiple organ dysfunction syndrome": 2.99, "nephropathy toxic": 34.23, "neurotoxicity": 14.4, "nocardiosis": 60.78, "off label use": 2.07, "peritonitis": 14.18, "polyomavirus-associated nephropathy": 67.93, "post transplant lymphoproliferative disorder": 27.7, "posterior reversible encephalopathy syndrome": 16.29, "premature baby": 9.23, "premature delivery": 7.95, "product use in unapproved indication": 3.29, "renal impairment": 6.12, "respiratory failure": 2.33, "sepsis": 2.25, "septic shock": 2.62, "skin lesion": 3.44, "squamous cell carcinoma of skin": 19.19, "staphylococcal infection": 4.86, "thrombotic microangiopathy": 23.36, "toxicity to various agents": 14.96, "transplant rejection": 48.57, "tuberculosis": 7.14, "varicella zoster virus infection": 23.41}